Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Int J Med Microbiol ; 305(8): 860-4, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26365168

RESUMO

Antibiotic resistance is an unsolved healthcare problem with increasing impact on patient management in the last years. In particular, multidrug resistance among Gram-negative bacterial strains has become the most pressing challenge. In order to deliver the most efficacious antimicrobial therapy with minimum delay, rapid diagnostic tests are required in order to detect multidrug resistant pathogens early during infection. In line with these efforts, we have developed a mass spectrometry-based assay for the rapid determination of ampicillin and cefotaxime resistance. The assay quantifies beta-lactamase activities towards ampicillin and cefotaxime within a turnaround time of 150 min, which is substantially faster than classical susceptibility testing.


Assuntos
Antibacterianos/metabolismo , Cefotaxima/metabolismo , Cromatografia Líquida/métodos , Escherichia coli/efeitos dos fármacos , Escherichia coli/enzimologia , Espectrometria de Massas/métodos , beta-Lactamases/análise , Ampicilina/metabolismo , Técnicas Bacteriológicas/métodos , Humanos , Fatores de Tempo , Resistência beta-Lactâmica
2.
J Clin Microbiol ; 50(5): 1727-9, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22322351

RESUMO

Early targeted antimicrobial therapy helps decrease costs and prevents the spread of antimicrobial resistance, including in Escherichia coli, the most frequent Gram-negative bacterium that causes sepsis. Therefore, rapid susceptibility testing represents the major prerequisite for knowledge-based successful antimicrobial treatment. To accelerate testing for antibiotic susceptibility, we have developed a new mass spectrometry-based assay for antibiotic susceptibility testing (MAAST). For proof of principle, we present an ampicillin susceptibility test for E. coli with a turnaround time of 90 min upon growth detection.


Assuntos
Resistência a Ampicilina , Ampicilina/farmacologia , Antibacterianos/farmacologia , Escherichia coli/efeitos dos fármacos , Espectrometria de Massas/métodos , Humanos , Testes de Sensibilidade Microbiana/métodos , Fatores de Tempo
3.
Horm Metab Res ; 42(2): 130-6, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19882501

RESUMO

Female Wistar-Kyoto rats (WKY) show a 4-day estrous cycle. The aim of this study was to examine the impact of 17beta-estradiol supplementation every fourth day to ovariectomized rats - mimicking the physiological estrous cycle - on regulation of blood pressure. We monitored blood pressure telemetrically in intact females, ovariectomized (OVX), and ovariectomized WKY injected subcutaneously with 17beta-estradiol (OVX (E2)) in a 4-day rhythm for 24 weeks. Blood pressure decreased both in intact females and OVX (E2), whereas that of OVX persisted at constant levels. The underlying mechanisms studied include the nitric oxide pathway, the rennin-angiotensin system as well as the endothelin system. Serum and urinary nitrate/nitrite (NOx) as well as aortic eNOS decreased in OVX and were restored to normal in OVX (E2). Conversely, caveolin-1 was higher in OVX than in intact females and OVX (E2) while Hsp90 did not differ among groups. Plasma angiotensin II and aortic AT (1) receptor expression increased in OVX and were normalized in OVX (E2). AT (2) receptor expression was regulated reciprocally. Serum endothelin-1 was significantly elevated in OVX and OVX (E2). There was no difference in aortic ET (A) receptor expression between groups whereas ET (B) receptor expression was higher in intact females and OVX (E2) than in OVX. The study suggests that supplementation of 17beta-estradiol in female WKY according to the natural estrous cycle maintains the physiological blood pressure encompassing vasorelaxing and vasoconstricting pathways. The physiological estrous cycle should be kept in mind when cardiovascular data are to be collected/interpreted under estrogen supplementation.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Estradiol/administração & dosagem , Ciclo Estral/efeitos dos fármacos , Ovariectomia , Angiotensina II/metabolismo , Animais , Endotelina-1/metabolismo , Estradiol/sangue , Estradiol/urina , Feminino , Injeções Subcutâneas , Óxido Nítrico Sintase Tipo III/metabolismo , Ratos , Ratos Endogâmicos WKY , Receptor de Endotelina A/metabolismo , Receptor de Endotelina B/metabolismo , Sistema Renina-Angiotensina/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA